Trial Profile
Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 May 2014
Price :
$35
*
At a glance
- Drugs SYI 2074 (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Synvista Therapeutics
- 10 May 2014 New trial record